Flexion Therapeutics, Inc. logo

Flexion Therapeutics, Inc. FLXN

$ 9.12 0.0%

Country

usaUSA

IPO year

2014

Industry

Drug manufacturers

Stock Exchange

NASDAQ GLOBAL

CEO

Dr. Michael Clayman

Employees in the company

288

Shares

42.8 M

Market Cap[1]

$ 459 M

EBITDA (LTM)

$ 224 M

P/E (LTM)

-

P/S (LTM)

-

EPS (LTM)

-

Other stocks of industry "Drug manufacturers"

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.